drugset / Trial / NCT07647783

A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets

NCT07647783 ↗

Phase 1 Recruiting 112 enrolled InnovStone Therapeutics Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a first-in-human study to evaluate the safety, tolerability, PK, and PD characteristics of SYH2072 Tablets after single and multiple oral doses in healthy participants.

Timeline

Start
2026-01-15
Primary completion
2027-02-01
Completion
2027-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject SYH2072 Unknown — Oral

Indications

No indication recorded.